Olaparib and pancreatic cancer: A challenging Lesson

被引：1
|
作者：
Louvet, Christophe [1 ]
Samalin, Emmanuelle [2 ]
Michel, Pierre [3 ]
机构：
[1] Inst Mutualiste Montsouris, Dept Med Oncol, F-75014 Paris, France
[2] Univ Montpellier, Inst Canc Montpellier Val Aurelle, Unite Oncol Gigest, Grp Digestif Unicanc, F-34298 Montpellier 5, France
[3] Normandie Univ, Hop Univ Rouen, Serv Hepatogastroenterol, UNIROUEN,Inserm 1245,IRON Grp,FFCD, F-76000 Rouen, France
来源：
BULLETIN DU CANCER | 2019年 / 106卷 / 09期
关键词：
D O I：
10.1016/j.bulcan.2019.07.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：715 / 716
页数：2
相关论文
共 50 条
  • [41] Pancreatic Teratoma: A Challenging Diagnosis of Pancreatic Cyst
    Sharma, Konika
    Afrooz, Mahyar
    Boddhula, Satish K.
    Raymond, Pascale
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S769 - S770
  • [42] POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC).
    Schwartz, Lawrence Howard
    Kindler, Hedy L.
    Hammel, Pascal
    Reni, Michele
    Van Cutsem, Eric
    Macarulla, Teresa
    Hall, Michael J.
    Park, Joon Oh
    Hochhauser, Daniel
    Arnold, Dirk
    Oh, Do-Youn
    Reinacher-Schick, Anke C.
    Tortora, Giampaolo
    Algul, Hana
    O'Reilly, Eileen Mary
    Fromageau, Jeremie
    Ghiorghiu, Dana C.
    McGuinness, David
    Locker, Gershon Y.
    Golan, Talia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [43] VIDEO IN AN ENGLISH LESSON AS A MEANS OF CHALLENGING CRITITAL THINKING
    Rigo, Frantisek
    MARKETING IDENTITY: OFFLINE IS THE NEW ONLINE, 2019, : 936 - 953
  • [44] Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ovarian cancer syndrome
    Tsuneizumi, Michiko
    Terada, Shuzo
    Usui, Takeshi
    Yamaguchi, Kei
    Hayami, Ryosuke
    Matsunuma, Ryoichi
    OXFORD MEDICAL CASE REPORTS, 2022, 2022 (11):
  • [45] Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer
    Kawamoto, Yasuharu
    Yamai, Takuo
    Ikezawa, Kenji
    Seiki, Yusuke
    Watsuji, Ko
    Hirao, Takeru
    Urabe, Makiko
    Kai, Yugo
    Takada, Ryoji
    Mukai, Kaori
    Nakabori, Tasuku
    Uehara, Hiroyuki
    Inoue, Tazuko
    Fujisawa, Fumie
    Ohkawa, Kazuyoshi
    BMC CANCER, 2024, 24 (01)
  • [46] Olaparib for the treatment of ovarian cancer
    Lheureux, Stephanie
    Oza, Amit M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 497 - 508
  • [47] Olaparib in the treatment of ovarian cancer
    Washington, Christina R.
    Richardson, Debra L.
    Moore, Kathleen N.
    FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
  • [48] Olaparib for the treatment of breast cancer
    Robert, Marie
    Frenel, Jean-Sebastien
    Gourmelon, Carole
    Patsouris, Anne
    Augereau, Paule
    Campone, Mario
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (06) : 751 - 759
  • [49] Challenging Topics in Pancreatic Neoplasia
    Basturk, Olca
    Krasinskas, Alyssa M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (07) : 806 - 807
  • [50] Pancreatic Tuberculosis: A Challenging Diagnosis
    Hoilat, Gilles J.
    Ayas, Mohamad F.
    Durer, Ceren
    Durer, Seren
    Manocha, Divey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S716 - S716
12345